Clinical Policy Title: Vacuum assisted closure in surgical wounds

Size: px
Start display at page:

Download "Clinical Policy Title: Vacuum assisted closure in surgical wounds"

Transcription

1 Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Number: Effective Date: September 1, 2015 Initial Review Date: June 16, 2013 Most Recent Review Date: August 17, 2017 Next Review Date: August 2018 Related policies: Policy contains: Vacuum assisted closure. Negative pressure wound closure. Negative pressure wound therapy. None. ABOUT THIS POLICY: Select Health of South Carolina has developed clinical policies to assist with making coverage determinations. Select Health of South Carolina s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional societies, and peerreviewed professional literature. These clinical policies along with other sources, such as plan benefits and state and federal laws and regulatory requirements, including any state- or plan-specific definition of medically necessary, and the specific facts of the particular situation are considered by Select Health of South Carolina when making coverage determinations. In the event of conflict between this clinical policy and plan benefits and/or state or federal laws and/or regulatory requirements, the plan benefits and/or state and federal laws and/or regulatory requirements shall control. Select Health of South Carolina s clinical policies are for informational purposes only and not intended as medical advice or to direct treatment. Physicians and other health care providers are solely responsible for the treatment decisions for their patients. Select Health of South Carolina s clinical policies are reflective of evidence-based medicine at the time of review. As medical science evolves, Select Health of South Carolina will update its clinical policies as necessary. Select Health of South Carolina s clinical policies are not guarantees of payment. Coverage policy Select Health of South Carolina considers vacuum assisted wound therapy (VAWT) clinically proven, and, therefore, medically necessary, when a wound despite conventional treatment and minimal activity of comorbidities is refractory to closure. Limitations: Select Health of South Carolina considers VAWT investigational and therefore not medically necessary where contraindications to its use exist (i.e., exposed organs and anastomoses, malignancy, necrotic eschar, fistulae, or osteomyelitis). VAWT is considered investigational and therefore not medically necessary for all other applications not meeting the criteria cited above. Alternative covered services: A primary care physician, surgeon, wound care specialist, or other qualified provider may evaluate a 1

2 patient for alternative covered services including routine office consultation and clinical investigation (i.e., laboratory, imaging, functional, testing and diagnostic procedures, specifically wound culture or biopsy). Background The merits of VAWT (also known as negative pressure wound therapy or NPWT) have been studied in a number of clinical contexts in the outpatient setting for a variety of wounds such as ulcers related to pressure sores, venous or arterial insufficiency, or neuropathy. It is important to note that these devices are adjunctive therapy that is not intended to replace good basic wound care (i.e., daily wound measurements of dimension and depth, wet dressing applications, necrotic debridement, adequate overall nutrition, and minimization of disease activity of comorbid conditions). Among the numerous indications for use of this technology are: decubitus (pressure) ulcers, neuropathic ulcers, ulcers related to venous or arterial insufficiency, dehisced wounds or wounds with exposed hardware or bone, post-sternotomy wound infection or mediastinitis, or complications of a surgically created wound where accelerated granulation therapy is necessary and cannot be achieved by other available topical wound treatment. Searches Select Health of South Carolina searched PubMed and the databases of: UK National Health Services Centre for Reviews and Dissemination. Agency for Healthcare Research and Quality s National Guideline Clearinghouse and other evidence-based practice centers. The Centers for Medicare & Medicaid Services (CMS). We conducted searches on June 27, Searched terms were: "vacuum wound closure" (MeSH), "negative pressure wound therapy" (MeSH), and "NWPT" (MeSH). We included: Systematic reviews, which pool results from multiple studies to achieve larger sample sizes and greater precision of effect estimation than in smaller primary studies. Systematic reviews use predetermined transparent methods to minimize bias, effectively treating the review as a scientific endeavor, and are thus rated highest in evidence-grading hierarchies. Guidelines based on systematic reviews. Economic analyses, such as cost-effectiveness, and benefit or utility studies (but not simple cost studies), reporting both costs and outcomes sometimes referred to as efficiency studies which also rank near the top of evidence hierarchies. 2

3 Findings There is a growing body of evidence regarding NPWT as a therapeutic intervention following surgery. A prospective review (Selvagi, 2014) assigned 50 post-operative Crohn s disease patients to treatment with either portable VAWT (n = 25) or conventional dressings (n = 25). At one year of follow up, patients receiving VAWT had fewer surgical site complications, resulting in shorter hospital stays. At last follow up, readmission rates were lower. A Cochrane systematic review (Dumville, 2013) inclusive of 605 individuals with diabetes mellitus (DM) compared NPWT with standard moist wound dressings. Post-amputation wounds healed faster in the NPWT group compared with the moist dressing group: (risk ratio 1.44; 95 percent CI 1.03 to 2.01). The available evidence suggests that negative pressure wound therapy is more effective in healing postoperative foot wounds in people with DM compared with moist wound dressings. VAWT has also been studied as a prophylactic method of avoiding infections and wound dehiscence in high-risk extremity fractures below the knee. An industry-sponsored study (Stannard, 2012) reported the results of a randomized controlled trial (RCT) of 249 adult subjects with 263 lower extremity fractures undergoing open surgical repair. Subjects were randomized to receive post-operative NPWT (n = 130) or standard wound dressings (n = 119). There was a borderline statistically significant difference (P = 0.049) between groups with regard to post-operative infections, with the control group developing 5 (4 percent) acute and 18 (15 percent) late infections, and the NPWT group having 1 (0.7 percent) acute and 13 (9 percent) delayed infections. Wound dehiscence was reported in 20 (16.5 percent) of control subjects and 12 (8.6 percent) of NPWT subjects (p = 0.044). A Cochrane systematic review (Webster, 2012) of 162 patients with partial foot amputation wounds up to the transmetatarsal level found those assigned to NPWT (n = 77) delivered through the Vacuum Assisted Closure (VAC ) therapy system healed faster than controls (P = 0.005). The rate of granulation tissue formation, based on the time to percent formation in the wound bed, was faster in the NPWT group than in controls (P = 0.002). The frequency and severity of adverse events (of which the most common was wound infection) were similar in both treatment groups. An RCT (Doss, 2002) included 42 patients that developed post-sternotomy osteomyelitis and required open wound management. Twenty of these patients were treated by VAWT and the other 22 by conventional wound management. Patients treated by VAWT had a significantly reduced treatment duration (mean 17.2+/-5.8 vs /-10.8 days, P = 0.009) and total hospital stay (mean 27.2+/-6.5 vs /-11.0 days, P = 0.03). Evidence for the effectiveness of NPWT on complete healing of wounds expected to heal by primary 3

4 intention is convincing in multiple environments of care. There are clear cost benefits when noncommercial systems are used to create the negative pressure required for wound therapy, with no reduction in clinical outcome. Pain and readmission to the hospital is also diminished in patients receiving NPWT. Policy updates: The European Wound Management Association (EWMA) has published guidelines (Apelqvist 2017) for NPWT when used as a primary treatment of chronic wounds, in complex acute wounds and as an adjunct for temporary closure and wound bed preparation (e.g., preceding surgical procedures such as skin grafts and flap surgery). Despite an increasing number of papers on the efficacy of NPWT, due to the low evidence level the treatment remains controversial with regard to evidence-based medicine. Despite advances in surgical technique, ventral hernia repair (VHR) remains associated with significant post-operative wound complications. A systematic review and meta-analysis (Swanson, 2016) was performed to identify whether the application of NPWT following VHR reduces the risk of post-operative wound complications and hernia recurrence. Outcomes assessed included surgical site infection, wound dehiscence, seroma, and hernia recurrence. Five retrospective cohort studies including 477 patients undergoing VHR were included in the final analysis. The use of NPWT decreased surgical site infections (OR 0.33 [95 percent CI 0.20 to 0.55]; P<0.0001), wound dehiscence (OR 0.21 [95 percent CI 0.08 to 0.55]; P = 0.001), and ventral hernia recurrence (OR 0.24 [95 percent CI 0.08 to 0.75]; P = 0.01). There was no statistically significant difference in the incidence of seroma formation (OR 0.59 [95 percent CI 0.27 to 1.27]; P = 0.18). For patients undergoing VHR, current evidence suggests a decreased incidence in wound complications using incisional NPWT compared with conventional dressings. Summary of clinical evidence: Citation Apelqvist (2017) Content, Methods, Recommendations EWMA Document: Negative Pressure Wound Therapy. The ongoing controversy regarding high-level evidence in wound care in general is well known. There is a consensus that clinical practice should be evidence-based, which can be difficult to achieve due to confusion about the value of the various approaches to wound management. Reviews of the value of various treatment strategies for non-healing wounds, which have highlighted methodological inconsistencies in primary research. This situation is confounded by differences in the advice given by regulatory and reimbursement bodies in various countries regarding both study design and the ways in which results are interpreted. EWMA has been publishing a number of interdisciplinary documents with the intention of highlighting: o The nature and extent of the problem for wound management: from the clinical perspective as well as that of care givers and the patients 4

5 Citation Swanson (2016) Content, Methods, Recommendations o Evidence-based practice as an integration of clinical expertise with the best available clinical evidence from systematic research o The nature and extent of the problem for wound management: from the policy maker and healthcare system perspectives o The controversy regarding the value of various approaches to wound management and care is illustrated by the case of NPWT, synonymous with topical negative pressure or vacuum therapy and cited as branded vacuumassisted closure (VAC) therapy. Does negative pressure wound therapy applied to closed incisions following ventral hernia repair prevent wound complications and hernia recurrence? A systematic review and meta-analysis A systematic review and meta-analysis inclusive of 477 patients was performed to identify whether the application of NPWT to closed incisions following VHR reduces the risk of post-operative wound complications and hernia recurrence. The use of inpwt decreased SSI (OR 0.33 [95% CI 0.20 to 0.55]; P<0.0001), wound dehiscence (OR 0.21 [95% CI 0.08 to 0.55]; P = 0.001), and ventral hernia recurrence (OR 0.24 [95% CI 0.08 to 0.75]; P = 0.01). There was no statistically significant difference in the incidence of seroma formation (OR 0.59 [95% CI 0.27 to 1.27]; P = 0.18). The authors concluded that for patients undergoing VHR, current evidence suggests a decreased incidence in wound complications using incisional NPWT compared with conventional dressings. Selvaggi (2014) New advances in negative pressure wound therapy (NPWT) for surgical wounds of patients affected with Crohn's disease Dumville (2013) Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus Armstrong (2012) During , 50 patients with Crohn s disease were assigned to post-operative treatment with either NPWT (n = 25) or conventional dressings (n = 25). Parameters of interest were surgical site and operative complications, and readmission rates. Patients receiving NPWT had fewer wound complications, resulting in shorter hospital stays. No differences were observed in surgical complications between groups. No patients needed to come back to the hospital for device malfunctioning or inability to manage the device. Incisional NPWT was applied to the closed surgical incisions of patients randomized to the study treatment vice standard post-operative dressings to the control patients. There were a total of 23 infections in controls versus 14 in treated patients, a significant difference in favor of NPWT (P = 0.049). The relative risk of developing an infection was 1.9 times higher in control patients than in patients treated with NPWT (95% confidence interval, ). Comparative effectiveness of mechanically and electrically powered A study of 162 diabetic patients considered whether NPWT improves the proportion and rate of wound healing after partial foot amputation in patients with diabetes. Inclusion criteria consisted of partial foot amputation wounds up to the transmetatarsal level and evidence of adequate perfusion. 5

6 Citation negative pressure wound therapy devices: a multicenter randomized controlled trial Webster (2012) Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention Doss (2002) Vacuum-assisted suction drainage versus conventional treatment in the management of poststernotomy osteomyelitis Content, Methods, Recommendations Patients who were randomly assigned to NPWT (n = 77) received treatment with dressing changes every 48 h. Control patients (n = 85) received standard moist wound care according to consensus guidelines. More patients healed in the NPWT group than in the control group (43 [56%] versus 33 [39%], P = 0.040). The rate of wound healing, based on the time to complete closure, was faster in the NPWT group than in controls (p = 0.005). The rate of granulation tissue formation, based on the time to 76% 100% formation in the wound bed, was faster in the NPWT group than in controls (P = 0.002). The frequency and severity of adverse events (of which the most common was wound infection) were similar in both treatment groups. A Cochrane review of five eligible trials with a total of 280 participants compared standard dressings with NPWT and found the adverse event rate was similar between groups (negative pressure 33/86; standard dressing 37/103); risk ratio (RR) 0.97 (95% confidence intervals [CI] 0.33 to 2.89). There was significant heterogeneity for this result due to the high incidence of fracture blisters in the NPWT group in one trial. One trial (87 participants) compared a commercial negative pressure device VAC system with a negative pressure system developed in the hospital (GSUC). The adverse event rate was lower in the GSUC group (VAC 3/42; GSUC 0/45); the RR was 0.13 (95% CI 0.01 to 2.51). The mean cost to supply equipment for VAC therapy was USD 96.51/day compared to USD 4.22/day for the GSUC therapy (P = 0.01). Pain intensity score was also reported to be lower in the GSUC group when compared with the VAC group (p = 0.02). Post-operative VAWT was compared to conventional wound management in 42 patients that developed post-sternotomy osteomyelitis and required open wound management. The patients were comparable with regards to age, presenting post-operative day, infecting organism, and risk factors for osteomyelitis. The patients treated by VAWT had significantly reduced treatment durations (mean 17.2+/- 5.8 vs /-10.8 days, P = 0.009) and total hospital stays (mean 27.2+/-6.5 vs / days, P = 0.03). Perioperative mortality was similar, with one early death in each group. References Professional society guidelines/other: Dumville JC, Hinchliffe RJ, Cullum N, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev. 2013; (10):CD

7 Webster J, Scuffham P, Sherriff KL, et al. Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev. 2012; (4):CD Peer-reviewed references: Apelqvist J, Willy C, Fagerdahl AM, et al. EWMA Document: Negative Pressure Wound Therapy. J Wound Care. 2017;26(Sup3):S1-S154. Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: a multicenter randomized controlled trial. Wound Rep Reg. 2012; 20(3): Doss M, Martens S, Wood JP, et al. Vacuum-assisted suction drainage versus conventional treatment in the management of poststernotomy osteomyelitis. Eur J Cardiothorac Surg. 2002; 22(6): Selvaggi F, Pellino G, Sciaudone G, et al. New advances in negative pressure wound therapy (NPWT) for surgical wounds of patients affected with Crohn's disease. Surg Technol Int. 2014; 24: Swanson EW, Cheng HT, Susarla SM, Lough DM, Kumar AR. Does negative pressure wound therapy applied to closed incisions following ventral hernia repair prevent wound complications and hernia recurrence? A systematic review and meta-analysis. Plast Surg (Oakv). 2016; 24(2): CMS National Coverage Determination (NCDs): No NCDs identified as of the writing of this policy. Local Coverage Determinations (LCDs): No LCDs identified as of the writing of this policy. Commonly submitted codes Below are the most commonly submitted codes for the service(s)/item(s) subject to this policy. This is not an exhaustive list of codes. Providers are expected to consult the appropriate coding manuals and bill accordingly. CPT Codes Description Comments Negative pressure wound therapy (e.g., vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters 7

8 CPT Codes Description Comments Negative pressure wound therapy (e.g., vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters ICD 10 Codes Description Comments An appropriate ICD-10 diagnosis code describing the wound that is being treated should be used when reporting vacuum-assisted wound closure. HCPCS Level II Codes A6550 A9272 E2402 Description Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories Wound suction, disposable, includes dressing, all accessories and components, any type, each Negative pressure wound therapy electrical pump, stationary or portable Comments 8

Clinical Policy Title: Vacuum assisted closure in surgical wounds

Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Number: 17.03.00 Effective Date: September 1, 2015 Initial Review Date: June 16, 2013 Most Recent Review Date: July 3,

More information

Negative Pressure Wound Therapy (NPWT)

Negative Pressure Wound Therapy (NPWT) Negative Pressure Wound Therapy (NPWT) Policy Number: Original Effective Date: MM.01.005 11/19/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 01/01/2015 Section: DME Place(s) of Service:

More information

Clinical Policy Title: Cardiac rehabilitation

Clinical Policy Title: Cardiac rehabilitation Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review

More information

Premier Health Plan considers Negative Pressure Wound Therapy (NPWT) in the home setting medically necessary for the following indications:

Premier Health Plan considers Negative Pressure Wound Therapy (NPWT) in the home setting medically necessary for the following indications: Premier Health Plan POLICY AND PROCEDURE MANUAL PA.009.PH Negative Pressure Wound Therapy This policy applies to the following lines of business: Premier Commercial Premier Employee Premier Health Plan

More information

Clinical Policy Title: Genicular nerve block

Clinical Policy Title: Genicular nerve block Clinical Policy Title: Genicular nerve block Clinical Policy Number: 14.01.10 Effective Date: October 1, 2017 Initial Review Date: September 21, 2017 Most Recent Review Date: October 19, 2017 Next Review

More information

Clinical Policy Title: Strep testing

Clinical Policy Title: Strep testing Clinical Policy Title: Strep testing Clinical Policy Number: 07.01.09 Effective Date: December 1, 2017 Initial Review Date: October 19, 2017 Most Recent Review Date: November 16, 2017 Next Review Date:

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

Clinical Policy Title: Zoster (shingles) vaccine

Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Number: 18.02.10 Effective Date: June 1, 2018 Initial Review Date: April 10, 2018 Most Recent Review Date: May 1, 2018 Next Review Date:

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

Disclosures. Outpatient NPWT Options Free up Hospital Beds, but Do They Work? Objectives. Clinically Effective: Does it Work?

Disclosures. Outpatient NPWT Options Free up Hospital Beds, but Do They Work? Objectives. Clinically Effective: Does it Work? 4/16/16 Disclosures Consultant, Volcano Corporation Outpatient Options Free up Hospital Beds, but Do They Work? UCSF Vascular Symposium 16 Jonathan Labovitz, DPM Medical Director, Foot & Ankle Center Associate

More information

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent

More information

POLICIES AND PROCEDURE MANUAL

POLICIES AND PROCEDURE MANUAL POLICIES AND PROCEDURE MANUAL Policy: MP058 Section: Medical Benefit Policy Subject: Negative Pressure Wound Therapy I. Policy: Negative Pressure Wound Therapy II. Purpose/Objective: To provide a policy

More information

QUICK GUIDE SNAP THERAPY SYSTEM

QUICK GUIDE SNAP THERAPY SYSTEM QUICK GUIDE SNAP THERAPY SYSTEM Clinical Pathway to SNAP System Full holistic assessment of patient and wound Is the wound type indicated for NPWT use without contraindications 1? SNAP System is indicated

More information

NEGATIVE PRESSURE WOUND THERAPY

NEGATIVE PRESSURE WOUND THERAPY NEGATIVE PRESSURE WOUND THERAPY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices

More information

Negative Pressure Wound Therapy

Negative Pressure Wound Therapy Origination: 6/29/04 Revised: 8/24/16 Annual Review: 11/10/16 Purpose: To provide Negative Pressure Wound Therapy (wound care treatment) guidelines for the Medical Department staff to reference when making

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Topical Negative Pressure Therapy for Wounds File Name: Origination: Last CAP Review: Next CAP Review: Last Review: topical_negative_pressure_therapy_for_wounds 12/1998 5/2018

More information

Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab

Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Number: 01.01.03 Effective Date: January 1, 2016 Initial Review Date: September 16, 2015 Most Recent

More information

ACTIVE INCISION MANAGEMENT: A PLAN FOR PROTECTING YOUR SURGICAL RESULTS, YOUR PATIENTS AND YOUR HOSPITAL.

ACTIVE INCISION MANAGEMENT: A PLAN FOR PROTECTING YOUR SURGICAL RESULTS, YOUR PATIENTS AND YOUR HOSPITAL. ACTIVE INCISION MANAGEMENT: A PLAN FOR PROTECTING YOUR SURGICAL RESULTS, YOUR PATIENTS AND YOUR HOSPITAL. How active hands-on involvement in managing the incision healing process helps to protect your

More information

Clinical Policy Title: Ketamine for treatment-resistant depression

Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Number: 00.02.13 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January

More information

Clinical Policy Title: Breast cancer index genetic testing

Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Number: 02.01.22 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2016

More information

Clinical Policy Title: Debridement of diabetic foot ulcers

Clinical Policy Title: Debridement of diabetic foot ulcers Clinical Policy Title: Debridement of diabetic foot ulcers Clinical Policy Number: CCP.1200 Effective Date: January 1, 2016 Initial Review Date: October 19, 2015 Most Recent Review Date: October 2, 2018

More information

Negative Pressure Wound Therapy in the Outpatient Setting

Negative Pressure Wound Therapy in the Outpatient Setting Negative Pressure Wound Therapy in the Outpatient Setting Policy Number: 1.01.16 Last Review: 9/2017 Origination: 7/2001 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will

More information

Clinical Policy: Low-Frequency Ultrasound Therapy for Wound Management Reference Number: CP.MP.139 Last Review Date: 01/18

Clinical Policy: Low-Frequency Ultrasound Therapy for Wound Management Reference Number: CP.MP.139 Last Review Date: 01/18 Clinical Policy: Low-Frequency Ultrasound Therapy for Wound Management Reference Number: CP.MP.139 Last Review Date: 01/18 See Important Reminder at the end of this policy for important regulatory and

More information

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Platelet rich plasma Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2017 Next Review

More information

See Policy CPT/HCPCS CODE section below for any prior authorization requirements

See Policy CPT/HCPCS CODE section below for any prior authorization requirements Effective Date: 7/1/2018 Section: DME Policy No: 377 Medical Officer 7/1/18 Date Technology Assessment Committee Approved Date: 10/10; 10/13; 9/14: 9/15; 4/16 Medical Policy Committee Approved Date: 3/03;

More information

Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering)

Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Number: 17.02.02 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent

More information

The Use of the. in Clinical Practice

The Use of the. in Clinical Practice The Use of the SNAP Therapy System in Clinical Practice It s an ultraportable, mechanically-powered disposable NPWT. By Animesh Bhatia, DPM, CWS This article is written exclusively for PM and appears courtesy

More information

Topical Oxygen Wound Therapy (MEDICAID)

Topical Oxygen Wound Therapy (MEDICAID) Topical Oxygen Wound Therapy (MEDICAID) Last Review Date: September 8, 2017 Number: MG.MM.DM.15C8v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or

More information

VACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur

VACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur VACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur Learning Objectives Define Negative Pressure Wound Therapy (NPWT) Discuss guidelines for the

More information

NEGATIVE PRESSURE WOUND THERAPY

NEGATIVE PRESSURE WOUND THERAPY Oxford NEGATIVE PRESSURE WOUND THERAPY UnitedHealthcare Oxford Clinical Policy Policy Number: SURGERY 110.1 T2 Effective Date: January 1, 2019 Instructions for Use Table of Contents Page CONDITIONS OF

More information

Durable Medical Equipment Providers

Durable Medical Equipment Providers August 2009 Provider Bulletin Number 974 Durable Medical Equipment Providers Vacuum Assisted Wound Closure Therapy Negative pressure wound therapy (NPWT) must be requested and supplied by an enrolled durable

More information

Clinical Policy Title: Bloodless heart transplant

Clinical Policy Title: Bloodless heart transplant Clinical Policy Title: Bloodless heart transplant Clinical Policy Number: 05.03.05 Effective Date: July 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next Review Date:

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Vacuum Assisted Wound Closure (VAC) Page 1 of 25 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Vacuum Assisted Wound Closure (VAC) Professional Institutional Original

More information

Clinical Policy Title: Platelet rich plasma

Clinical Policy Title: Platelet rich plasma Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review

More information

Coverage Summary. Wound Treatments

Coverage Summary. Wound Treatments Coverage Summary Wound Treatments Policy Number: W-001 Products: UnitedHealthcare Medicare Advantage Plans Original Approval Date: 02/18/2009 Approved by: UnitedHealthcare Medicare Benefit Interpretation

More information

Clinical Policy Title: Bone growth stimulators for non-healing fractures

Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Number: 14.02.03 Effective Date: January 1, 2015 Initial Review Date: July 16, 2014 Most Recent Review Date: March

More information

Clinical Policy Title: Computerized gait analysis

Clinical Policy Title: Computerized gait analysis Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: May 1, 2018 Next Review Date:

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Vacuum Assisted Wound Closure (VAC) Page 1 of 32 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Vacuum Assisted Wound Closure (VAC) Professional Institutional Original

More information

Clinical Policy Title: Room humidifiers

Clinical Policy Title: Room humidifiers Clinical Policy Title: Room humidifiers Clinical Policy Number: 17.02.05 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review Date:

More information

Clinical Policy Title: Outpatient diabetes self-management training (DSMT)

Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Number: 06.02.02 Effective Date: July 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: March

More information

Clinical Policy Title: Air fluidized beds

Clinical Policy Title: Air fluidized beds Clinical Policy Title: Air fluidized beds Clinical Policy Number: 16.02.10 Effective Date: May 1, 2018 Initial Review Date: March 6, 2018 Most Recent Review Date: April 10, 2018 Next Review Date: April

More information

Clinical Policy Title: Computerized gait analysis

Clinical Policy Title: Computerized gait analysis Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: June 22, 2017 Next Review Date:

More information

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 11.03.05 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: September 21, 2017 Next

More information

Negative Pressure Wound Therapy (NPWT) (Vacuum-Assisted Wound Closure)

Negative Pressure Wound Therapy (NPWT) (Vacuum-Assisted Wound Closure) Negative Pressure Wound Therapy (NPWT) (Vacuum-Assisted Wound Closure) Date of Origin: 03/2018 Last Review Date: 03/28/2018 Effective Date: 03/28/2018 Dates Reviewed: 03/2018 Developed By: Medical Necessity

More information

Negative Pressure Wound Therapy in the Outpatient Setting. Original Policy Date 12:2013

Negative Pressure Wound Therapy in the Outpatient Setting. Original Policy Date 12:2013 MP 1.01.11 Negative Pressure Wound Therapy in the Outpatient Setting Medical Policy Section Durable Medical Equipment Issue 12:2013` Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature

More information

First Coast Service Options (FCSO) Medicare Policy Primer

First Coast Service Options (FCSO) Medicare Policy Primer First Coast Service Options (FCSO) Medicare Policy Primer Medicare Jurisdiction (JN) Florida, Puerto Rico and U.S. Virgin Islands Application of Skin Substitute Grafts for the treatment of DFU and VLU

More information

Negative Pressure Wound Therapy

Negative Pressure Wound Therapy Ontario Health Technology Assessment Series 2010; Vol. 10, No. 22 Negative Pressure Wound Therapy An Evidence Update Presented to the Ontario Health Technology Advisory Committee in September 2010 December

More information

Clinical Policy Title: Statin use in adults and children

Clinical Policy Title: Statin use in adults and children Clinical Policy Title: Statin use in adults and children Clinical Policy Number: 04.02.09 Effective Date: May 1, 2016 Initial Review Date: February 17, 2016 Most Recent Review Date: September 21, 2017

More information

Negative Pressure Wound Therapy Pumps

Negative Pressure Wound Therapy Pumps Negative Pressure Wound Therapy Pumps Adopted from the National Government Services website. For any item to be covered by The Health Plan, it must: 1. Be eligible for a defined Medicare or The Health

More information

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent

More information

NEGATIVE PRESURE WOUND THERAPY PROGRAM

NEGATIVE PRESURE WOUND THERAPY PROGRAM NEGATIVE PRESURE WOUND THERAPY PROGRAM WWW.USTOMWOUNDCARE.COM 866-802-0006/901-619-8897 SUPPORT@USTOM.COM TABLE OF CONTENTS 1. 2. 3. 4. To place an order: 1. Please visit our website 2. Please email to

More information

Sympathetic Electrical Stimulation Therapy for Chronic Pain

Sympathetic Electrical Stimulation Therapy for Chronic Pain Sympathetic Electrical Stimulation Therapy for Chronic Pain Policy Number: 015M0076A Effective Date: April 01, 015 RETIRED 5/11/017 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION COVERAGE

More information

The VERSAJET II Hydrosurgery System

The VERSAJET II Hydrosurgery System Precise Excision The VERSAJET II Hydrosurgery System The VERSAJET II Hydrosurgery System The VERSAJET II system enables a surgeon to precisely select, excise and evacuate nonviable tissue, bacteria and

More information

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most

More information

Protocol. Negative Pressure Wound Therapy in the Outpatient Setting

Protocol. Negative Pressure Wound Therapy in the Outpatient Setting Protocol Negative Pressure Wound Therapy in the Outpatient Setting (10116) Medical Benefit Effective Date: 07/01/18 Next Review Date: 05/19 Preauthorization No Review Dates: 11/07, 09/08, 09/09, 09/10,

More information

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications Clinical Policy Title: Pharmacogenomic tests for psychiatric medications Clinical Policy Number: 02.02.01 Effective Date: October 1, 2015 Initial Review Date: April 15, 2015 Most Recent Review Date: May

More information

o Venous edema o Stasis ulcers o Varicose veins (not including spider veins) o Lipodermatosclerosis

o Venous edema o Stasis ulcers o Varicose veins (not including spider veins) o Lipodermatosclerosis Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Effective for dates of service on or after July 1, 2018, wound care equipment and supply benefits will change for Texas

More information

1/5. Introduction. Primary endpoint Time to reach readiness for closure by surgical intervention or left for closure by secondary intention

1/5. Introduction. Primary endpoint Time to reach readiness for closure by surgical intervention or left for closure by secondary intention 1/5 Introduction Materials and methods Animal studies show that intermittent NPWT has potential to increase the rate of granulation tissue formation compared with adjustable intermittent (AI) NPWT 1 However,

More information

Clinical Policy Title: Subtalar arthroereisis (implant)

Clinical Policy Title: Subtalar arthroereisis (implant) Clinical Policy Title: Subtalar arthroereisis (implant) Clinical Policy Number: 14.03.05 Effective Date: April 1, 2017 Initial Review Date: August 17, 2016 Most Recent Review Date: September 21, 2017 Next

More information

Negative-pressure wound therapy (NPWT) is

Negative-pressure wound therapy (NPWT) is WOU HEALING Negative-Pressure Wound Therapy: A Comprehensive Review of the Evidence Ersilia L. Anghel, BS, BA Paul J. Kim, DPM, MS, FACFAS Washington, D.C. Background: Negative-pressure wound therapy (NPWT)

More information

Determining Wound Diagnosis and Documentation Tips Job Aid

Determining Wound Diagnosis and Documentation Tips Job Aid Determining Wound Diagnosis and Job Aid 1 Coding Is this a traumatic injury from an accident? 800 Codes - Injury Section of the Coding Manual Code by specific site of injury. Only use for accidents or

More information

Clinical Policy Title: Propel (drug eluting devices after sinus surgery)

Clinical Policy Title: Propel (drug eluting devices after sinus surgery) Clinical Policy Title: Propel (drug eluting devices after sinus surgery) Clinical Policy Number: 10.03.07 Effective Date: July 1, 2017 Initial Review Date: May 19, 2017 Most Recent Review Date: June 22,

More information

Clinical Policy Title: Epidermal nerve fiber density testing

Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: CCP.1263 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 2, 2018

More information

Clinical Policy Title: Rib fixation

Clinical Policy Title: Rib fixation Clinical Policy Title: Rib fixation Clinical Policy Number: CCP.1395 Effective Date: September 1, 2018 Initial Review Date: July 3, 2018 Most Recent Review Date: August 1, 2018 Next Review Date: August

More information

V.A.C. Therapy Patient Guide. Are you suffering from a wound? Ask your doctor about V.A.C. Therapy and whether it may be right for you.

V.A.C. Therapy Patient Guide. Are you suffering from a wound? Ask your doctor about V.A.C. Therapy and whether it may be right for you. V.A.C. Therapy Patient Guide Are you suffering from a wound? Ask your doctor about V.A.C. Therapy and whether it may be right for you. kci1.com 800.275.4524 Table of Contents Wound Healing is a Process...2

More information

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)

Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most

More information

Clinical Policy: EpiFix Wound Treatment

Clinical Policy: EpiFix Wound Treatment Clinical Policy: Reference Number: PA.CP.MP.140 Effective Date: 03/18 Last Review Date: 04/18 Coding Implications Revision Log Description EpiFix (MiMedx Group) is dehydrated human amniotic tissue that

More information

Clinical Policy Title: Ear tubes (tympanostomy)

Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 1135 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: August 1, 2018 Next Review

More information

Clinical Policy Title: Propel (drug eluting devices after sinus surgery)

Clinical Policy Title: Propel (drug eluting devices after sinus surgery) Clinical Policy Title: Propel (drug eluting devices after sinus surgery) Clinical Policy Number: 10.03.07 Effective Date: July 1, 2017 Initial Review Date: May 19, 2017 Most Recent Review Date: May 1,

More information

Clinical Policy Title: Discography

Clinical Policy Title: Discography Clinical Policy Title: Discography Clinical Policy Number: 03.01.01 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2017 Next Review Date: October

More information

Clinical Policy Title: Investigational (experimental) health services

Clinical Policy Title: Investigational (experimental) health services Clinical Policy Title: Investigational (experimental) health services Clinical Policy Number: 18.04.03 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: September

More information

Use of Biologics in Abdominal Wall Reconstruction

Use of Biologics in Abdominal Wall Reconstruction Use of Biologics in Abdominal Wall Reconstruction Mike K. Liang Associate Professor of Surgery McGovern Medical School University of Texas Health Science Center Houston, Texas Disclosures No Financial

More information

Cahaba Medicare Policy Primer 1,2 for Apligraf

Cahaba Medicare Policy Primer 1,2 for Apligraf Cahaba Medicare Policy Primer 1,2 for Apligraf MAC A: AL, GA & TN MAC B: AL, GA, & TN LCD# 31428 Indications Applied to partial- or full-thickness ulcers of the lower extremities (see individual product

More information

Clinical Policy Title: Hammer toe surgery

Clinical Policy Title: Hammer toe surgery Clinical Policy Title: Hammer toe surgery Clinical Policy Number: 18.03.04 Effective Date: July 1, 2016 Initial Review Date: July 15, 2016 Most Recent Review Date: May 1, 2018 Next Review Date: May 2019

More information

The Efficacy of NPWT on Primary Closed Incisions

The Efficacy of NPWT on Primary Closed Incisions The Efficacy of NPWT on Primary Closed Incisions Pieter Zwanenburg Researcher / PhD Candidate Marja Boermeester Professor of Surgery, Academic Medical Center, Amsterdam Incisional Negative Pressure Wound

More information

Clinical Policy Title: Tumor treatment fields for glioblastoma

Clinical Policy Title: Tumor treatment fields for glioblastoma Clinical Policy Title: Tumor treatment fields for glioblastoma Clinical Policy Number: 05.02.05 Effective Date: July 1, 2015 Initial Review Date: March 18, 2015 Most Recent Review Date: April 19, 2017

More information

Corporate Medical Policy Investigational (Experimental) Services

Corporate Medical Policy Investigational (Experimental) Services Corporate Medical Policy Investigational (Experimental) Services File Name: Origination: investigational_(experimental)_services 1/1996 Description of Procedure or Service BCBSNC defines the terms "investigational"

More information

Description. Section: Durable Medical Equipment Effective Date: July 15, 2016

Description. Section: Durable Medical Equipment Effective Date: July 15, 2016 Last Review Status/Date: June 2016 Page: 1 of 18 Description Negative pressure wound therapy (NPWT) consists of the use of a negative pressure or suction device to aspirate and remove fluids, debris, and

More information

Postoperative Surgical Site Infection after Incisional Hernia Repair: Link to Previous Surgical Site Infection? Zulfiqar Ali, AG Rehan

Postoperative Surgical Site Infection after Incisional Hernia Repair: Link to Previous Surgical Site Infection? Zulfiqar Ali, AG Rehan Original Article Postoperative Surgical Site Infection after Incisional Hernia Repair: Link to Previous Surgical Site Infection? Zulfiqar Ali, AG Rehan ABSTRACT Objective: Aim of the study was to determine

More information

HYSTERECTOMY FOR BENIGN CONDITIONS

HYSTERECTOMY FOR BENIGN CONDITIONS UnitedHealthcare Commercial Medical Policy HYSTERECTOMY FOR BENIGN CONDITIONS Policy Number: 2018T0572G Effective Date: September 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

NPWT Case Series EXPERIENCES WITH INVIA MOTION. Precious life Progressive care. Invia Motion Negative Pressure Wound Therapy

NPWT Case Series EXPERIENCES WITH INVIA MOTION. Precious life Progressive care. Invia Motion Negative Pressure Wound Therapy NPWT Case Series EXPERIENCES WITH INVIA MOTION Invia Motion Negative Pressure Wound Therapy Precious life Progressive care npwt_case_booklet_a4.indd 1 18.12.13 13:17 Chronic sacral pressure ulcer Case

More information

Clinical Policy Title: Pediatric rhinoplasty

Clinical Policy Title: Pediatric rhinoplasty Clinical Policy Title: Pediatric rhinoplasty Clinical Policy Number: 11.03.06 Effective Date: October 1, 2017 Initial Review Date: August 17, 2017 Most Recent Review Date: September 21, 2017 Next Review

More information

Clinical Policy Title: Uvulopalatopharyngoplasty

Clinical Policy Title: Uvulopalatopharyngoplasty Clinical Policy Title: Uvulopalatopharyngoplasty Clinical Policy Number: 10.03.05 Effective Date: October 1, 2015 Initial Review Date: June 17, 2015 Most Recent Review Date: July 20, 2017 Next Review Date:

More information

HIGH- VOLTAGE PULSED CURRENT (HVPC) ELECTRICAL STIMULATION FOR TREATMENT OF DIABETIC FOOT ULCER (DFU) - A REVIEW

HIGH- VOLTAGE PULSED CURRENT (HVPC) ELECTRICAL STIMULATION FOR TREATMENT OF DIABETIC FOOT ULCER (DFU) - A REVIEW Review Article Allied Science International Journal of Pharma and Bio Sciences ISSN 0975-6299 HIGH- VOLTAGE PULSED CURRENT (HVPC) ELECTRICAL STIMULATION FOR TREATMENT OF DIABETIC FOOT ULCER (DFU) - A REVIEW

More information

Icd 10 wound vac change

Icd 10 wound vac change Icd 10 wound vac change The Borg System is 100 % Icd 10 wound vac change Sep 23, 2015. A compilation of helpful resources for wound care practices to support the transition to ICD-10, including trainings,

More information

ALLIANCE OF WOUND CARE STAKEHOLDERS. Palmetto GBA Public Meeting Draft LCD on Application of Skin Substitutes (DL36466) October 13, 2015

ALLIANCE OF WOUND CARE STAKEHOLDERS. Palmetto GBA Public Meeting Draft LCD on Application of Skin Substitutes (DL36466) October 13, 2015 ALLIANCE OF WOUND CARE STAKEHOLDERS Palmetto GBA Public Meeting Draft LCD on Application of Skin Substitutes (DL36466) October 13, 2015 1 ALLIANCE OF WOUND CARE Who is the Alliance? STAKEHOLDERS A non-profit

More information

Medicare Podiatry Services: Information for Medicare Fee-For-Service Health Care Professionals

Medicare Podiatry Services: Information for Medicare Fee-For-Service Health Care Professionals R DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services FACT SHEET Medicare Podiatry Services: Information for Medicare Fee-For-Service Health Care Professionals Overview This

More information

Clinical Policy Title: Tactile breast imaging

Clinical Policy Title: Tactile breast imaging Clinical Policy Title: Tactile breast imaging Clinical Policy Number: 05.01.07 Effective Date: February 1, 2018 Initial Review Date: November 16, 2017 Most Recent Review Date: January 11, 2018 Next Review

More information

Description. Section: Medicine Effective Date: April 15, 2015 Subsection: Medicine Original Policy Date: September 13, 2012 Subject:

Description. Section: Medicine Effective Date: April 15, 2015 Subsection: Medicine Original Policy Date: September 13, 2012 Subject: Last Review Status/Date: March 2015 Description Page: 1 of 6 Low-frequency ultrasound (US) in the kilohertz (KHz) range may improve wound healing. Several noncontact devices have received regulatory approval

More information

Clinical Policy Title: Seasonal influenza testing

Clinical Policy Title: Seasonal influenza testing Clinical Policy Title: Seasonal influenza testing Clinical Policy Number: 07.01.08 Effective Date: October 1, 2017 Initial Review Date: August 17, 2017 Most Recent Review Date: September 21, 2017 Next

More information

Clinical Policy Title: Cryoneurolysis

Clinical Policy Title: Cryoneurolysis Clinical Policy Title: Cryoneurolysis Clinical Policy Number: 09.02.08 Effective Date: May 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review Date: April 19, 2017 Next Review Date: April 2018

More information